Applying cryopreserved amniotic membrane following intravitreal injection

CAM encourages corneal healing in patients with ocular surface disease.

No ocular manifestations associated with inflammatory bowel disease, study finds

In a study, investigators found that no characteristics of inflammatory bowel disease are related to ocular manifestations of the disease.

Weekly review in ophthalmology: 6-12 August

An end-of-week review of what happened in ophthalmology from 6 to 12 August 2022.

Intravenous bevacizumab repackaged for intravitreal use: Making the sight-saving treatment safer

August 10, 2022

Although off-label repackaged bevacizumab syringes appear to satisfy an urgent clinical and financial need for patients with a variety of retinal disorders, they are known to be associated with considerable public health concerns due to the risks posed to patients from compounding pharmacies’ lack of compliance with a variety of FDA requirements.